National Amphetamine-Type Stimulant Strategy Background Paper: Monograph Series No. 69
Acknowledgements
This research would not have been possible without the assistance and support provided by a diverse range of stakeholders who provided both verbal and written submissions to this report. Many attended public consultations and provided helpful follow-up material. The authors are especially grateful to those users of amphetamine-type stimulants who provided invaluable insights on their own personal use and possible avenues for prevention and treatment. The assistance of Ms Jenny McLaren from the National Drug and Alcohol Research Centre (NDARC, UNSW) in providing advice based on development of the National Cannabis Strategy is greatly appreciated. The guidance and support of Mr Peter Rogers and Mr Jeremy Williams from the Australian Government Department of Health and Ageing is acknowledged. Finally, thanks are extended to NDRI and AIC colleagues who provided valuable assistance throughout the project and the preparation of this report.
